Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date How can synthetic control arms & real-world data redefine clinical trial design? David Clifton, University of Oxford; Mark Winderlich, MorphoSys Inc; Martin Gouldstone, Sensyne Health Synthetic Control Arms (SCAs) have the potential to reduce the number of trial participants, eliminate delays, and lower costs. In this webinar expert... 1 year ago | 59 mins The Expanding Role of RWE in Rare Studies Premier Consulting – Shari Medendorp, MPH, President, and Nach Davé, RPh, MS, Vice President, Development Strategy Real-world evidence is increasingly important in drug development as the medical and pharma communities recognize the data’s potential for predicting ... 6 months ago | 57 mins The Expanding Role of RWE in Rare Studies Premier Consulting – Shari Medendorp, MPH, President, and Nach Davé, RPh, MS, Vice President, Development Strategy Real-world evidence is increasingly important in drug development as the medical and pharma communities recognize the data’s potential for predicting ... 8 months ago | 63 mins “The bots are coming" — Robotic identities and the future of financial crime Frank Badalamenti - Principal PwC, Martin Rehak - CEO Resistant AI and James Brodhurst - Consultant Resistant AI The last 2 years were a game changer for financial crime — but they’re just a sign of things to come. Fraud-tech is at an inflection point, and could ... 11 months ago | 37 mins Launderbots, or why your AML is no longer fit for purpose Jan Philippaerts VP Compliance Currencycloud, Kathy Gormley Solutions Engineer and James Brodhurst Consultant - Resistant AI Those 200 limited-edition Yeezys that were just scalped off a custom footwear store by an army of bots weren’t just doing it for the markup. They’re d... 12 months ago | 35 mins
